Medtronic to shed 1,500-1,800 jobs

Reeling from a 69 percent drop in fourth-quarter profits, Medtronic says it's going to slash 1,500 to 1,800 jobs as part of an effort to streamline its operations. Some 400 workers already have accepted buyout offers, and they'll depart at the end of this month. So that leaves another 1,100 to 1,400 pink slips to go by the end of June.

The planned cuts come on top of a previous restructuring program, which resulted in a $27 million charge to earnings during Medtronic's most recent quarter, plus another as-yet-to-be-specified charge for the current quarter. And the layoffs aren't a complete surprise; CEO William Hawkins had discussed the possibility with employees back in February.

In other cost-cutting moves, Medtronic has instituted a salary freeze and plans to shave executive pay by 5 percent.

Meanwhile, the company is actually hiring in some areas. In fact, it's among the very few that are staffing up on the sales side. CFO Gary Ellis said during a conference call with analysts and media that some 500 sales jobs are being added, with 700 new jobs on the roster overall during this fiscal year.

- read the Dow Jones story

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.